Lu Alleruzzo News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The Series B funding for Immunophotonics comes as it recently dosed the first patients in a second phase of a clinical trial in Switzerland.

Miguel zubizarretaLu alleruzzoJim mckelveyZubizoom investmentsHyland softwareOhio based hylandLouis business